Early research (Phase 1)Looking for participantsNCT07430397
What this trial is testing
A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults, Adults With FV Leiden or Prothrombin G20210A Mutation, and Adults With a History of Provoked Venous Thromboembolism
Who this might be right for
Factor V LeidenProthrombin G20210AVenous Thromboembolism (VTE)
City Therapeutics 182